PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 128 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,726,000 | -14.9% | 983,090 | +9.3% | 0.00% | 0.0% |
| Q3 2016 | $12,598,000 | +120.8% | 899,246 | +10.6% | 0.00% | +100.0% |
| Q2 2016 | $5,706,000 | +9.3% | 812,757 | +0.2% | 0.00% | 0.0% |
| Q1 2016 | $5,221,000 | -80.0% | 810,772 | +0.4% | 0.00% | -75.0% |
| Q4 2015 | $26,157,000 | +23.9% | 807,313 | +2.1% | 0.00% | 0.0% |
| Q3 2015 | $21,117,000 | -30.9% | 790,897 | +24.5% | 0.00% | -20.0% |
| Q2 2015 | $30,576,000 | -12.9% | 635,285 | +10.1% | 0.01% | 0.0% |
| Q1 2015 | $35,101,000 | +65.5% | 576,838 | +40.8% | 0.01% | +66.7% |
| Q4 2014 | $21,211,000 | +97.0% | 409,707 | +67.4% | 0.00% | +50.0% |
| Q3 2014 | $10,769,000 | +57.7% | 244,702 | -6.3% | 0.00% | +100.0% |
| Q2 2014 | $6,828,000 | +85.8% | 261,195 | +85.8% | 0.00% | 0.0% |
| Q1 2014 | $3,675,000 | +109.4% | 140,595 | +36.0% | 0.00% | – |
| Q4 2013 | $1,755,000 | +43.1% | 103,414 | +81.0% | 0.00% | – |
| Q3 2013 | $1,226,000 | – | 57,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
| RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
| GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
| SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
| Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
| ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
| Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
| Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
| Chubb Ltd | 8,180 | $387,000 | 1.10% |